Dose-Escalated SBRT for Borderline and Locally Advanced Pancreatic Cancer: Resectability Rate and Pathological Results of a Multicenter Prospective Study.

Cancers (Basel) · 2025 · PMC11763360 · PMID 39857973

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a possible trendno p-value reported

The results suggest a possible trend of an association favoring BED ≥ 100 in improving surgical resectability, highlighting the potential impact of ablative-dose SBRT in enhancing surgical outcomes for BRPC and LAPC previously considered unresectable.

also in 633 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.